At the end of the latest market close, Humanigen Inc. (HGEN) was valued at $0.17. In that particular session, Stock kicked-off at the price of $0.1618 while reaching the peak value of $0.1665 and lowest value recorded on the day was $0.1514. The stock current value is $0.15.Recently in News on November 14, 2022, Humanigen Reports Third Quarter 2022 Financial Results. Short Hills, New Jersey–(Newsfile Corp. – November 14, 2022) – Humanigen, Inc. (Nasdaq: HGEN) (Humanigen), a clinical-stage biopharmaceutical company focused on developing lenzilumab (LENZ®), a first-in class antibody that neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF), today reported financial results for the third quarter and nine months ended September 30, 2022. You can read further details here
Humanigen Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.1050 on 03/21/22, with the lowest value was $0.1300 for the same time period, recorded on 11/09/22.
Humanigen Inc. (HGEN) full year performance was -97.46%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Humanigen Inc. shares are logging -97.71% during the 52-week period from high price, and 17.46% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.13 and $6.66.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1257113 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Humanigen Inc. (HGEN) recorded performance in the market was -95.90%, having the revenues showcasing -50.21% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 17.72M, as it employees total of 11 workers.
The Analysts eye on Humanigen Inc. (HGEN)
During the last month, 0 analysts gave the Humanigen Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.4013, with a change in the price was noted -1.62. In a similar fashion, Humanigen Inc. posted a movement of -91.37% for the period of last 100 days, recording 7,797,255 in trading volumes.
Technical rundown of Humanigen Inc. (HGEN)
Raw Stochastic average of Humanigen Inc. in the period of last 50 days is set at 17.64%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 51.59%. In the last 20 days, the company’s Stochastic %K was 71.74% and its Stochastic %D was recorded 79.24%.
Considering, the past performance of Humanigen Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -95.90%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -92.86%, alongside a downfall of -97.46% for the period of the last 12 months. The shares increased approximately by -6.38% in the 7-day charts and went down by 1.80% in the period of the last 30 days. Common stock shares were lifted by -50.21% during last recorded quarter.